Imcivree is a Subcutaneous Solution in the Human Prescription Drug category. It is labeled and distributed by Rhythm Pharmaceuticals, Inc. The primary component is Setmelanotide.
Product ID | 72829-010_2c075332-ae2c-4be0-8ba7-309536362c7e |
NDC | 72829-010 |
Product Type | Human Prescription Drug |
Proprietary Name | Imcivree |
Generic Name | Setmelanotide |
Dosage Form | Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2020-12-14 |
Marketing Category | NDA / NDA |
Application Number | NDA213793 |
Labeler Name | Rhythm Pharmaceuticals, Inc |
Substance Name | SETMELANOTIDE |
Active Ingredient Strength | 10 mg/mL |
Pharm Classes | Melanocortin 4 Receptor Agonist [EPC], Melanocortin 4 Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2020-12-14 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() IMCIVREE 90178986 not registered Live/Pending |
Rhythm Pharmaceuticals, Inc. 2020-09-14 |
![]() IMCIVREE 88226182 not registered Live/Pending |
Rhythm Pharmaceuticals, Inc. 2018-12-12 |